Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
7
NMPA:7
Drug Approvals
Mepivacaine Hydrochloride Injection
- Product Name
- 盐酸甲哌卡因注射液
- Approval Number
- 国药准字H20244513
- Approval Date
- Jul 30, 2024
NMPA
Acetylcysteine Solution for Inhalation
- Product Name
- 吸入用乙酰半胱氨酸溶液
- Approval Number
- 国药准字H20244557
- Approval Date
- Jul 30, 2024
NMPA
Salbutamol Sulfate Solution for Inhalation
- Product Name
- 吸入用硫酸沙丁胺醇溶液
- Approval Number
- 国药准字H20244092
- Approval Date
- Jun 18, 2024
NMPA
Ropivacaine Hydrochloride and Sodium Chloride Injection
- Product Name
- 盐酸罗哌卡因氯化钠注射液
- Approval Number
- 国药准字H20203053
- Approval Date
- Feb 25, 2020
NMPA
Clinical Trials
No trials found
News
No news found